| Name | HMB-Val-Ser-Leu-VE |
|---|---|
| Synonyms |
N-(3-Hydroxy-2-methylbenzoyl)-L-valyl-N-[(2E,4S)-1-ethoxy-6-methyl-1-oxo-2-hepten-4-yl]-L-serinamide
N-(3-hydroxy-2-methylbenzoyl)-L-valyl-N-[(2E,4S)-1-ethoxy-6-methyl-1-oxohept-2-en-4-yl]-L-serinamide L-Serinamide, N-(3-hydroxy-2-methylbenzoyl)-L-valyl-N-[(1S,2E)-4-ethoxy-1-(2-methylpropyl)-4-oxo-2-buten-1-yl]- |
| Description | HMB-Val-Ser-Leu-VE is a prototype vinyl ester inhibitor. HMB-Val-Ser-Leu-VE is against trypsin-like (T-L) proteasome activity with an IC50 of 0.033 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: prototype vinyl ester[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 754.1±60.0 °C at 760 mmHg |
| Molecular Formula | C26H39N3O7 |
| Molecular Weight | 505.60 |
| Flash Point | 409.8±32.9 °C |
| Exact Mass | 505.278809 |
| PSA | 154.06000 |
| LogP | 4.16 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.539 |